Literature DB >> 11713289

E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

J W Zhu1, S J Field, L Gore, M Thompson, H Yang, Y Fujiwara, R D Cardiff, M Greenberg, S H Orkin, J DeGregori.   

Abstract

E2F activity is critical for the control of the G(1) to S phase transition. We show that the combined loss of E2F1 and E2F2 results in profound effects on hematopoietic cell proliferation and differentiation, as well as increased tumorigenesis and decreased lymphocyte tolerance. The loss of E2F1 and E2F2 impedes B-cell differentiation, and hematopoietic progenitor cells in the bone marrow of mice lacking E2F1 and E2F2 exhibit increased cell cycling. Importantly, we show that E2F1 and E2F2 double-knockout T cells exhibit more rapid entry into S phase following antigenic stimulation. Furthermore, T cells lacking E2F1 and E2F2 proliferate much more extensively in response to subthreshold antigenic stimulation. Consistent with these observations, E2F1/E2F2 mutant mice are highly predisposed to the development of tumors, and some mice exhibit signs of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713289      PMCID: PMC100017          DOI: 10.1128/MCB.21.24.8547-8564.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

Review 1.  Immunology: improving on nature in the twenty-first century.

Authors:  A K Abbas; C A Janeway
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  E2F-1 functions in mice to promote apoptosis and suppress proliferation.

Authors:  S J Field; F Y Tsai; F Kuo; A M Zubiaga; W G Kaelin; D M Livingston; S H Orkin; M E Greenberg
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

3.  Tumor induction and tissue atrophy in mice lacking E2F-1.

Authors:  L Yamasaki; T Jacks; R Bronson; E Goillot; E Harlow; N J Dyson
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

Review 4.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

Review 5.  Positive versus negative signaling by lymphocyte antigen receptors.

Authors:  J I Healy; C C Goodnow
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.

Authors:  U Ziebold; T Reza; A Caron; J A Lees
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

7.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

8.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation.

Authors:  N Avitahl; S Winandy; C Friedrich; B Jones; Y Ge; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

9.  Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.

Authors:  L Yamasaki; R Bronson; B O Williams; N J Dyson; E Harlow; T Jacks
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

10.  Oncogenic capacity of the E2F1 gene.

Authors:  D G Johnson; W D Cress; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more
  42 in total

1.  Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.

Authors:  Blanca Scheijen; Marieke Bronk; Tiffany van der Meer; René Bernards
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

3.  A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.

Authors:  Xiaoqin Xu; Mark Bieda; Victor X Jin; Alina Rabinovich; Mathew J Oberley; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2007-10-01       Impact factor: 9.043

Review 4.  Too much to handle - how gaining chromosomes destabilizes the genome.

Authors:  Verena Passerini; Zuzana Storchová
Journal:  Cell Cycle       Date:  2016-09-16       Impact factor: 4.534

Review 5.  Interferon-inducible Ifi200-family genes in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Immunol Lett       Date:  2008-07-01       Impact factor: 3.685

6.  Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts.

Authors:  Alexandra Dirlam; Benjamin T Spike; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

7.  E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.

Authors:  Daniela S Castillo; Anna Campalans; Laura M Belluscio; Abel L Carcagno; J Pablo Radicella; Eduardo T Cánepa; Nicolás Pregi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.

Authors:  Jennifer E Cloud; Catherine Rogers; Tammi L Reza; Ulrike Ziebold; James R Stone; Michael H Picard; Alicia M Caron; Roderick T Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

9.  Reconstruction of gene regulatory modules in cancer cell cycle by multi-source data integration.

Authors:  Yuji Zhang; Jianhua Xuan; Benildo G de los Reyes; Robert Clarke; Habtom W Ressom
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

10.  A role for E2F activities in determining the fate of Myc-induced lymphomagenesis.

Authors:  Rachel E Rempel; Seiichi Mori; Maura Gasparetto; Michele A Glozak; Eran R Andrechek; Steven B Adler; Nina M Laakso; Anand S Lagoo; Robert Storms; Clay Smith; Joseph R Nevins
Journal:  PLoS Genet       Date:  2009-09-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.